Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | VB-111 |
| Trade Name | Ofranergene Obadenovec |
| Synonyms | VB111 |
| Drug Descriptions |
Ofranergene Obadenovec (VB-111) is an engineered adenovirus that expresses Fas-c specifically within endothelial cells, resulting in endothelial cell death and decreased tumor blood supply, and potentially leading to tumor cell death (PMID: 22701765) |
| DrugClasses | |
| CAS Registry Number | 1476737-24-2 |
| NCIT ID | C71539 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bevacizumab + VB-111 | Bevacizumab VB-111 | 0 | 2 |
| Nivolumab + VB-111 | Nivolumab VB-111 | 0 | 1 |
| Paclitaxel + VB-111 | Paclitaxel VB-111 | 0 | 1 |
| VB-111 | VB-111 | 0 | 1 |